Methylphenidate abuse and misuse in patients affected with a psychiatric disorder and a substance use disorder: a systematic review.

ABSTRACT:

Background

Methylphenidate (MPH), a central nervous system stimulant primarily prescribed for attention-deficit/hyperactivity disorder (ADHD), has seen increasing rates of misuse and abuse, particularly in patients with dual diagnosis (co-occurring psychiatric disorders and substance use disorders/SUDs). The heightened risk of dependence and adverse effects in these vulnerable populations warrants a systematic review to assess the prevalence and pattern of abuse/misuse of MPH among patients within this population and to understand potential risk factors, patterns of misuse, and outcomes, including the impact on psychiatric symptoms and overall mental health, the effects on SUD (e.g., exacerbation or mitigation of symptoms), and the incidence of adverse events and complications (e.g

SUBMITTER: Chiappini S 

PROVIDER: S-EPMC11609911 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature